Regulatory Aspects of Pharmaceuticals’ Exports in Gulf Cooperation Council Countries
| Autor: | Manthan D Janodia, Prashant B Musmade, Kranti B. Talole, Virendra S Ligade, Nayanabhirama Udupa, Y Kamariya, Praful B. Deshpande, S Pateriya, T Kulshrestha |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2011 |
| Předmět: |
business.industry
media_common.quotation_subject Pharmaceutical Marketing and Management food and beverages International trade Regulated market Destinations Recession humanities Economic slowdown Bilateral trade Exports Gulf cooperation council pharmaceutical Quality (business) General Pharmacology Toxicology and Pharmaceutics regulatory business Emerging markets health care economics and organizations media_common |
| Zdroj: | Journal of Young Pharmacists : JYP |
| ISSN: | 0975-1505 0975-1483 |
| Popis: | The Gulf cooperation council (GCC) region is considered as “Emerging market” for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slowdown in highly well-off and regulated market of the EU and US, raised the demand for alternate destinations for business. The regulations of Gulf countries are encouraging the import of quality generic products, which can be good news to the Indian drug manufacturers. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|